药物与临床
Liu Xiaoping;Li Xangyu;Wen Youseng
2000, 19(2): 140-141.
Objective:To get some knowledge of the effetiveness and safety of risperidone for female schizophrenic treatment.Methods:31 subjects was entered with CCMDⅡR schizophrenic diagnosis standard. Age 18~60 years, course of disease>3 months, BPRS≥27, the average dosage of risperidone was 3.26±1.18 mg/d, the duration of treatment was 16 weeks, BPRS, CGI were used to evaluate the medicine curative effect and TESS were use to evaluate the side effects.Results:Risperidone total effective rate was 96.77%, of which, significant response accounted for 74.19% (23/31), improvement accounted for 22.58% (7/31), invalidity accounted for 3.23%(1/31). The major side effects of the medicine were insomnia, constipation, EPS, weight gain, and lactation.Conclusion:Risperidone was effective and high safe for female schizophrenia.